Epigral informs about press release

27 Jan 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that it enclosed a Press Release for Un-Audited Financial Results - Q3 FY2025. The said Press Release is also available at www.epigral.com in the Investor Relations section.

The above information is a part of company’s filings submitted to BSE.


Epigral Share Price

1277.10 -41.80 (-3.17%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3897.70
Tata Chemicals 763.85
SRF 3102.70
Pidilite Inds. 1458.40
Deepak Nitrite 1765.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×